| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f776ef10140e02fda39170d86551c0a5 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L33-04 |
| filingDate |
1994-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_942040878d056d51c997c502e6450f12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ce90d97f44b23d1a9f3539da33642e6 |
| publicationDate |
1995-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H07316038-A |
| titleOfInvention |
Pharmaceutical composition for mucosal administration |
| abstract |
(57) [Summary] [Structure] A pharmaceutical composition for mucosal administration containing the following a) to d) as essential components. a) Alkyl acrylate (meth) acrylate copolymer or salt thereof b) Alkali metal salt and / or alkaline earth metal salt c) Drug d) Water [Effect] For adhering at mucosal site and sustaining effect Are better. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006521362-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008013572-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0014171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006117656-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4632499-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112708645-A |
| priorityDate |
1994-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |